Porcilis ERY suspension for injection for pigs

Maa: Irlanti

Kieli: englanti

Lähde: HPRA (Health Products Regulatory Authority)

Aktiivinen ainesosa:

Erysipelothrix rhusiopathiae strain m2 (serotype 2)

Saatavilla:

Intervet Ireland Limited

ATC-koodi:

QI09AB

INN (Kansainvälinen yleisnimi):

Erysipelothrix rhusiopathiae strain m2 (serotype 2)

Annos:

.

Lääkemuoto:

Suspension for injection

Prescription tyyppi:

LR: Licensed Retailer as defined in national legislation

Terapeuttinen ryhmä:

Pigs

Terapeuttinen alue:

Inactivated bacterial vaccines (including mycoplasma, toxoid and chlamydia)

Käyttöaiheet:

Immunological - Inactivated Vaccine

Valtuutuksen tilan:

Authorised

Valtuutus päivämäärä:

2001-04-10

Valmisteyhteenveto

1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
Porcilis Ery suspension for injection for pigs
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each 2 ml dose contains:
ACTIVE SUBSTANCE:
Inactivated lysed antigen concentrate of
_Erysipelothrix rhusiopathiae_
strain M2 (serotype 2): ≥
1ppd*
*ppd = pig protective dose, determined by reference to a standard
vaccine batch.
ADJUVANT:
dl-

-tocopherol acetate: 150mg
EXCIPIENTS:
For the full list of excipients, see Section 6.1.
3.
PHARMACEUTICAL FORM
Suspension for injection.
Aqueous white or nearly white liquid.
4.
CLINICAL PARTICULARS
4.1
TARGET SPECIES
Pigs (sows, gilts, boars and growing pigs).
4.2
INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
For active immunisation of healthy pigs to reduce clinical signs and
lesions caused by Erysipelas
disease. To maintain protection, animals should be re-vaccinated at no
more than six monthly
intervals.
4
.
3
CONTRAINDICATIONS
None.
4.4
SPECIAL WARNINGS FOR EACH TARGET SPECIES
Vaccinate healthy animals only.
4.5
SPECIAL PRECAUTIONS FOR USE
SPECIAL PRECAUTIONS FOR USE IN ANIMALS
Not applicable.
SPECIAL PRECAUTIONS TO BE TAKEN BY THE PERSON ADMINISTERING THE
VETERINARY MEDICINAL
PRODUCT TO ANIMALS
In case of accidental self-injection, seek medical advice immediately
and show the package leaflet
or the label to the physician. If spilled on the skin, wash with soap
and water. If ingested, drink
water. If symptoms develop, seek medical advice.
4.6
ADVERSE REACTIONS (FREQUENCY AND SERIOUSNESS)
Transient increases in body temperature (0.5°C) within 24 hours may
very commonly occur.
A
mild transient local swelling (less than 5cm in diameter, normally
within 3 days)
may
very commonly occur. Transient reluctance to move may commonly occur.
In post marketing experience:
In very rare cases, a hypersensitivity reaction may occur.
The frequency of adverse reactions is defined using the following
convention:
- very common (more than 1 in 10 animals treated displaying adverse
reaction(s))
- common (more than 1 but less than 10 animals in 100